Steadtrust’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Steadtrust's TEVA Position: Q2 2026 in Review
Steadtrust increased its Teva Pharmaceutical Industries (TEVA) stake by 0.55% in Q2 2026, buying an estimated $6.66K and bringing the position to 36,300 shares worth $1.23M. The position accounts for 0.62% of the portfolio, ranked #38.
Steadtrust first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 679 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Steadtrust held 36,300 shares of Teva Pharmaceutical Industries worth $1.23M as of Q2 2026.
- Steadtrust bought 200 Teva Pharmaceutical Industries shares in Q2 2026, an estimated $6.66K.
- Teva Pharmaceutical Industries made up 0.62% of Steadtrust's portfolio in Q2 2026, its #38 holding.
- Steadtrust first reported a position in Teva Pharmaceutical Industries in Q2 2025 and has held it in 5 quarters since.
- 679 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q2 2026.
Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.